Recent clinical observations have indicated that triglycerides containing medium chain fatty acids may be useful in decreasing steatorrhea associated with malabsorptive states such as pancreatic insufficiency and extrahepatic biliary tract obstruction (1, 2). This suggests that significant amounts of medium chain triglycerides may be absorbed under conditions in which there are decreased intraluminal concentrations of pancreatic enzymes or bile salts. However, few quantitative data are available regarding the intestinal hydrolysis and the rate of absorption of medium chain triglycerides as compared to long chain triglycerides.
Recent clinical observations have indicated that triglycerides containing medium chain fatty acids may be useful in decreasing steatorrhea associated with malabsorptive states such as pancreatic insufficiency and extrahepatic biliary tract obstruction (1, 2) . This suggests that significant amounts of medium chain triglycerides may be absorbed under conditions in which there are decreased intraluminal concentrations of pancreatic enzymes or bile salts. However, few quantitative data are available regarding the intestinal hydrolysis and the rate of absorption of medium chain triglycerides as compared to long chain triglycerides.
We have compared the intestinal hydrolysis and absorption of a medium chain triglyceride (trioctanoin) with those of a long chain triglyceride (tripalmitin) under a variety of experimental conditions. These studies were performed with isolated intestinal loops in the rat.
The data obtained indicate that there are significant differences in the rates of hydrolysis and absorption of trioctanoin compared to tripalmitin. We also observed that with decreased intraluminal concentrations of bile salts and pancreatic enzymes there was, as expected, decreased absorption of both trioctanoin and tripalmitin. However, under these conditions there was significantly less impairment in the absorption of trioctanoin. We also performed studies utilizing agents that inhibit protein synthesis and demonstrated additional differences in the absorption and transport of trioctanoin and tripalmitin.
Methods
Preparation and measurement of 'C-labeled lipid substrates. Sodium octanoate-l-"C and sodium palmitate-1-4C' were converted to the free fatty acid and along with tripalmitin-carboxyl-14C and trioctanoin-carboxyl-'C were purified by thin layer chromatography. The developing solvent system used for the palmitic acid and tripalmitin contained by volume 84.5% petroleum ether, 14% diethyl ether, and 1.4% glacial acetic acid. The solvent system for octanoic acid and trioctanoin contained by volume 57%o hexane, 41% diethyl ether, and 2% glacial acetic acid. All 1'C-labeled lipids used in these experiments were 98% pure. The fatty acid and triglyceride substrates were dissolved in a small amount of ether and homogenized in 10%o crystalline albumin with subsequent evaporation of the ether. Nonradioactive lipid carrier was added before homogenization so that the final concentration of the various lipid-albumin suspensions was either 5 or 10 jumoles lipid per ml.
Samples of the various '4C-labeled lipid-albumin suspensions were added to 12 ml of a solution of p-dioxane containing 5%o naphthalene, 0.01% p-bis-2'-(5'-phenyloxazolyl)benzene, 0.7%o p-bis-2,5-diphenyloxazole, and 13.3%o absolute ethanol and were counted in a Packard
Tri-Carb liquid scintillation spectrometer. The solution prepared for counting substances in organic solvents contained 15 ml of toluene with 4.0% Liquifluor.2 Quenching was corrected for by utilizing a standard quenching curve as described by Bush (3) .
Experiments on lipid absorption from isolated intestinal loops. With female rats weighing 160 to 180 g under light ether anesthesia, a laparotomy was performed, and a 20-to 30-cm segment of the lower duodenum and jejunum was isolated between double silk ligatures, care being taken not to obstruct the blood flow. In experiments in which normal intestinal loops were-utilized, the proximal ligature was placed at the pyloroduodenal 1 New England Nuclear Corp., Boston, Mass. 2 Pilot Chemicals, Watertown, Mass. junction above the entrance of the biliary and pancreatic ducts. In irrigated loops, which were employed to reduce intraluminal concentrations of pancreatic enzymes and bile salts, the isolated loops were flushed with 50 ml of 0.85% NaCl. The proximal ligature was then placed below the entrance of the biliary and pancreatic ducts. The various radioactive lipids, suspended in 10% albumin, were then injected into the loop in a volume of about 1 ml. After 15 minutes the isolated loops were excised and the intestinal contents washed out with 50 ml of 0.85% NaCl. The luminal contents were acidified with 1.0 ml of 12 N HCO and extracted with 100 ml of hexane. The aqueous and lipid phases were separated and samples assayed for radioactivity. The intestinal mucosa was removed from the loops by scraping, weighed, and the lipids extracted by the method of Folch, Lees, and Sloane Stanley (4) . In experiments with palmitic acid and tripalmitin as radioactive substances, the solvents containing. the extracted lipids were evaporated to dryness under a stream of nitrogen at room temperature and the residues redissolved in chloroform. In experiments with octanoic acid and trioctanoin as substrates, the chloroform-methanol (2:1) added during the experiment contained 42 jumoles of carrier octanoic acid and 6 umoles of carrier trioctanoin, and the pH during the Folch extraction was adjusted to below 3. Because of the volatility of octanoic acid, the solvents containing the lipid extracts were evaporated slowly under a nitrogen stream at 00 C.
Recovery of octanoic acid-"C under these conditions was greater than 95% in control studies. The dried extracts were then resuspended in chloroform. Samples of the lipid extracts were assayed for radioactivity and analyzed by thin layer chromatography.
The question might be raised as to whether some of the 4C-labeled lipid injected into isolated' loops was adsorbed to the intestinal mucosa thus resulting in a spuriously elevated mucosal uptake. To exclude this possibility, preliminary studies were carried out in which trioctanoincarboxyl-"C and tripalmitin-carboxyl-"C were injected into intestinal loops, which were excised within 30 seconds. Under these conditions greater than 90% of the "C-labeled lipid injected was recovered in the luminal contents. Although some adsorption of "C-labeled lipids to intestinal mucosa undoubtedly did occur, we felt it to be insignificant. Absorption of radioactive lipid substrates from isolated intestinal loops was also assessed by determining`C activity in portal venous and aortic blood, either 15 minutes or 60 minutes after the injection of the "C-labeled lipids. Plasma samples were extracted by the method of Folch and associates (4) and the aqueous and lipid extracts assayed for radioactivity. The lipids were also fractionated by thin layer chromatography.
Experiments with acetoxycycloheximide (ACH). Studies were carried out to determine the effect of inhibiting protein synthesis on the absorption of carboxyl-"C-trioctanoin and carboxyl-"C-tripalmitin. ACH, an antibiotic that has been found to inhibit protein synthesis in mammalian cells (5) , was injected intraperitoneally in a dosage of 0.25 mg per kg 4 hours before the preparation of the intestinal loops.
Studies on the hydrolysis of "C-labeled lipids in vitro. The previously described methods of Playoust and Isselbacher (6) were utilized in these studies. Crude pancreatic lipase 3 (4) . Samples of the lipid extracts were assayed for radioactivity and also fractionated by thin layer chromatography.
Results
Hydrolysis of trioctanoin and tripalmitin in vivo and in vitro. In Table I To confirm that trioctanoin is hydrolyzed more rapidly than tripalmitin, we undertook in vitro studies utilizing juice from either normal or irrigated intestinal loops (Table II) Table IV are shown data on the relative rates of absorption of trioctanoin and tripalmitin. These were determined by measuring the mucosal uptake and mucosal transfer of 14C-labeled lipids. Mucosal uptake (A) was determined by subtracting the amount of 14C-labeled lipid recovered in the loop contents from the amount injected. The amount of 14C-labeled lipid remaining in the mucosa (B) was determined directly. Mucosal transfer represents the difference between mucosal uptake (A) and the amount remaining in the mucosa (B). In essence therefore, mucosal transfer (A -B) reflects net absorption. When albumin suspensions of octanoic or pal. mitic acid were injected into irrigated loops, the mucosal uptakes were quite similar (86 vs. 81%).
However, with octanoic acid less 14C was recovered in the mucosa compared to palmitic acid (4 vs. 46%). Furthermore, in 15 minutes the mucosal transfer of octanoic acid was much greater than that of palmitic acid (82 vs. 35%).
When the triglycerides rather than the fatty acids were injected into normal loops, there was a greater mucosal uptake of trioctanoin than of tripalmitin (78 vs. 51%, p = < 0.001) and also a greater mucosal transfer of trioctanoin (71 vs. 31%, p = < 0.001). With irrigated loops, in which there was impaired intraluminal lipolysis, there was still a greater uptake of trioctanoin than of tripalmitin (53 vs. 40%, p = < 0.05) as well as a greater transfer (37 vs. 23%, p = < 0.05). Thus in both normal and irrigated loops the net absorption of trioctanoin was greater than that of tripalmitin. This is shown diagrammatically in Figure 1 .
The lipids present in intestinal mucosa and portal and aortic blood were analyzed by thin layer chromatography (Tables V and VI these experiments there was not enough radioac-uptake compared to controls (51 vs. 36%). Howtivity in the portal blood samples to permit mean-ever, the striking finding was the marked decrease ingful analysis by thin layer chromatography. in the mucosal transfer of tripalmitin, namely
Effect of inhibition of protein synthesis on ab-from 31%7 to 9%o (p = < 0.001).
sorption of 14C-labeled lipids. Since lipoproteins To document further the impaired transport of have been shown to be essential for the transport of tripalmitin after ACH treatment, we carried out long chain triglycerides from intestinal mucosa studies in which samples of portal and aortic blood (8, 9) , experiments were carried out with ACH were obtained 60 minutes after injection of tripalto determine the effect of impaired protein synthe-mitin into intestinal loops. The lipids were fracsis on the mucosal uptake and transfer of '4C-tionated by thin layer chromatography and samples labeled lipids from intestinal loops (Table VII) . assayed for radioactivity. In ACH rats receiving In studies.with trioctanoin, prior ACH treatment tripalmitin (Table VIII) there was a greater than resulted in a slight decrease in mucosal uptake 90% decrease in the amount of 14C-labeled lipid compared to controls (65 vs. 78%) as well as mu-recovered in aortic and portal blood compared to cosal transfer (52 vs. 71%o). Consistent with this controls. In similar studies with trioctanoin there latter finding was the twofold increase in 14C re-was only a minimal decrease in 14C-labeled lipid covered from the mucosa compared to controls (13 recovered in ACH-treated rats. vs. 6%o, Table VII ).
The ratio of 14C recovered in the portal vein After tripalmitin had been given to ACH-treated and the aorta reflects the different routes of transrats, there was a moderate decrease in mucosal port of trioctanoin and tripalmitin. The ratio of crosis, definite alterations in the villi and surface epithelium were noted (Figure 2 ). The villi appeared blunted due to edema of the villous core, and the surface epithelium showed focal areas of disorganization. This appearance was due in part to the extreme prominence of the mucous glands that were vacuolated, suggesting discharge of their contents. In previous experiments with puromycin and ethionine, no evidence of mucosal damage was noted by either light or electron microscopy (9-11).
Since ACH administration did result in apparent mucosal damage, studies were carried out to determine whether ACH treatment interfered with the mucosal processes of hydrolysis of trioctanoin and re-esterification of palmitic acid (Table IX) . When trioctanoin was injected into ACH-treated animals, 66% of the 14C-labeled lipid in the mucosa was present as fatty acid, a value nearly identical to. the control value of 67%o. When tripalmitin was given to ACH-treated rats, 76% of the labeled lipid in the mucosa was present as neutral lipid as compared with 83%o in controls. Thus ACH treatment dicd not interfere with the mucosal hydrolysis of trioctanoin or the re-esterification of palmitic acid to neutral lipids. These results are comparable to those observed with puromycin (9).
Discussion
Although it seems reasonably well established on the basis of in vitro studies (12, 13) that triglycerides containing medium chain fatty acids are hydrolyzed more rapidly than' long chain triglycerides, little quantitative data are available regarding rates of hydrolysis of triglycerides in vivo. The data obtained in the present investigation, based on in vivo and in vitro observations, indicate that trioctanoin, a medium chain triglyceride, is hydrolyzed by intestinal juice and pancreatic lipase more rapidly than tripalmitin, a long chain triglyceride. Furthermore, when intestinal loops are irrigated to impair intraluminal lipolysis, there is still a greater hydrolysis of trioctanoin than of tripalmitin. These data are consistent with previous in vitro observations of Desnuelle and his associates (12, 13) , who demonstrated that short and medium chain triglycerides are hydrolyzed more rapidly than long chain triglycerides. These authors have suggested that medium chain triglycerides may be split rapidly by pancreatic lipase because of an especially high rate of isomerization of medium chain 2-monoglycerides, and they have recently presented evidence that medium chain 2-monoglycerides do in fact isomerize very rapidly compared to long chain 2-monoglycerides (14) .
In view of earlier demonstrations of a mucosal lipase system capable of hydrolyzing trioctanoin, we wished to determine whether the more rapid hydrolysis of trioctanoin is due to the presence of this lipase system in intestinal juice. On the basis of the known properties of pancreatic and mucosal lipase (6) and the data in Table III , it is apparent that the lipolytic activity of the intestinal juice used in these studies had characteristics of pancreatic lipase rather than the mucosal lipase system.
In irrigated loops there was still a significant absorption of tripalmitin with 40% of the injected dose being taken up by the mucosa and 23% be-ing transferred. At first glance it would appear that there should not have been this much absorption of a long chain triglyceride in the presence of impaired intraluminal lipolysis. However, a tracer dose of 5 /moles was used, and therefore there was mucosal uptake of only 2 umoles and mucosal transfer of 1 Mmole of tripalmitin in 15 minutes. Moreover, these data are in agreement with an earlier study (6) in which there was mucosal uptake of 1 umole of tripalmitin in an irrigated intestinal loop in 10 minutes. In addition, some absorption'of long chain triglycerides has been shown to occur both in experimental animals (15) and man (16) (19, 20) and incorporated into mucosal triglycerides, via the monoglyceride-shunt pathway (21) (22) (23) or the glycerol phosphate-phosphatidic acid pathway (24) . Therefore, it was not surprising that after the injection of trioctanoin into normal loops the 14C-labeled lipid recovered both in the mucosa and portal blood was present primarily as fatty acid.
When trioctanoin was injected into an irrigated loop, however, the label recovered in the mucosa and portal blood was predominantly present in neutral lipid. These data suggest that when intraluminal lipolysis is impaired, some unhydrolyzed trioctanoin may enter the mucosal cell and be transported as such in the portal blood stream. For the reasons previously cited (19, 20) , it is unlikely that the trioctanoin recovered was the result of hydrolysis to octanoic acid followed by re-esterification in the intestinal mucosa.
In the study of Playoust and Isselbacher (6) it was demonstrated that after trioctanoin had been injected into an irrigated loop, 88%o of the labeled lipid in the mucosa was present as neutral lipid, but in the portal blood 85% of the "4C-labeled lipid was present as fatty acid. The latter observation is somewhat at variance with data presented in Table VI . In both studies, however, the 14C-labeled lipid recovered in the portal blood was only a small fraction of the administered dose, and thus the data can only be considered qualitative rather than quantitative. In addition, the portal blood was sampled at only one point in time, and the sampling time differed in the two studies. Obviously studies utilizing a continuous sampling technique are needed to define more clearly the quantitative aspects of trioctanoin transport in the portal blood stream. Nevertheless, it is evident from both studies that under certain conditions some unhydrolyzed trioctanoin may enter the mucosal cell and be transported as such.
As indicated previously, long chain fatty acids are esterified to triglycerides'it the intestinal mucosa and then incorporated along with phospholipids, cholesterol, and a protein coating into a lipoprotein moiety known as chylomicrons. The proteins of the chylomicron are probably those synthesized within the intestinal mucosa (8) . It has been demonstrated that after the administration of agents such as puromycin and ethionine, which inhibit protein and lipoprotein synthesis, the transport of long chain triglycerides is markedly impaired (9) (10) (11) .
In the present investigation ACH, an antibiotic derived from Streptomyces griseus and a potent inhibitor of protein synthesis in mammalian cells (5) , was utilized to determine its effect on lipid transport. The data obtained (Tables VII and  VIII) indicate that in ACH-treated animals the mucosal transfer of tripalmitin was markedly im-paired, presumably because chylomicron formation was interfered with. In contrast, the mucosal transfer of trioctanoin was only minimally decreased by ACH treatment. In similar studies with ethionine (11), there was also markedly impaired mucosal transfer of tripalmitin but no impairment in the transfer of trioctanoin. In this connection, it is pertinent to emphasize that in previous experiments with puromycin and ethionine, no evidence of mucosal damage was noted by either light or electron microscopy (9) (10) (11) . Possibly the minimal decrease in mucosal transfer of trioctanoin as well as the slight decrease in mucosal uptake of both trioctanoin and tripalmitin observed after ACH treatment was related to the fact that this drug was used in large doses that resulted in some morphologic alterations of the mucosa (Figure 2 ). Despite this apparent mucosal damage, there was not appreciable interference with the hydrolysis of trioctanoin and the re-esterification of palmitic acid to tripalmitin (Table IX) .
Recent studies by Valdivieso and Schwabe (25, 26) There is also clinical evidence bearing on the absorption of medium chain triglycerides when pancreatic enzymes and bile salts are deficient. Hashim, Roholt, and Van Itallie (1) noted that in a patient with pancreatic insufficiency, administration of a medium chain triglyceride mixture resulted in a decrease in steatorrhea from 49 to 4.6 g per day. Similarly Iber, Hardoon, and Sprague (2) demonstrated a decrease in the steatorrhea from 40 to 13 g per day in a patient with pancreatic insufficiency given medium chain triglycerides. Iber and colleagues (2) also reported that in a patient with biliary tract obstruction given medium chain triglycerides, the steatorrhea decreased from 80 to 5 g per day. Recently Zurier, Hashim, and Van Itallie (27) reported that medium chain triglycerides significantly decreased cholestyramine-induced steatorrhea.
Thus, although bile salts and pancreatic enzymes are evidently necessary for the optimal absorption of medium chain triglycerides, clinical observations and the present studies indicate that significant amounts of these triglycerides may be absorbed when pancreatic enzymes and bile salts are deficient. Summary Although recent clinical observations have indicated that medium chain triglycerides may be useful in malabsorptive states, little quantitative data are available regarding the rates of absorption of medium chain triglycerides as compared to long chain triglycerides. In the present investigation studies were carried out in which the intestinal hydrolysis and absorption of trioctanoin, a medium chain triglyceride, were compared with those of tripalmitin, a long chain triglyceride, under a variety of different experimental conditions. These studies were performed utilizing isolated intestinal loops in the rat. In addition to normal loops, irrigated loops were used so that studies could be carried out under conditions of diminished intraluminal lipolysis.
The data obtained in our study indicate that 1) trioctanoin is both hydrolyzed and absorbed more rapidly than tripalmitin; 2) with markedly diminished intraluminal concentrations of pancreatic lipase and bile salts there is decreased absorption of both trioctanoin and tripalmitin, but under these conditions there is significantly less impairment in the absorption of trioctanoin; and 3) after the administration of agents that inhibit protein synthesis, there is markedly impaired absorption of tripalmitin, but the effect on trioctanoin absorption is minimal.
